cdmo.directory
← Compare landing

Kincell Bio vs SCTbio

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryKincell BioSCTbio
SummaryLeading cell therapy CDMO delivering GMP manufacturing, analytics, and CMC strategy from early development through commercial launch across purpose-built U.S. facilities.SCTbio is a European cell and gene therapy CDMO offering cGMP manufacturing, lentiviral and gammaretroviral vector production, analytical development, and QP batch release. Its facilities include 420 m² of Class A/B/C GMP cleanrooms, and it reports more than 2,000 GMP batches manufactured.
Services
  • Cell Therapy Manufacturing
  • Process Development
  • CMC Analytical Development
  • Quality Control Testing
  • CMC Regulatory Submission Support
  • Viral Vector Manufacturing
  • Lentiviral Vector Manufacturing
  • Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Process Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • Cold-Chain Storage & Logistics
  • CMC Regulatory Submission Support
Modalities
  • Cell Therapy
  • Cell Therapy
  • Gene Therapy
Development capabilities
  • Analytical method development
  • Analytical method development
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Product (DP)
  • Expression: Viral Vector
Locations
  • Early CMC & Clinical Supply, Gainesville, FL, USA
  • Pivotal & Commercial Manufacturing, Research Triangle Park, NC, USA
  • Global Headquarters & EU Business Office, Prague, Praha, Czech Republic
  • US Business Office, Boston, MA, USA
CertificationsData not yet provided.Data not yet provided.

Find similar companies

Kincell Bio alternatives · SCTbio alternatives

Markdown mirror: /compare/kincellbio/sctbio.md